Abstract:Dysfunctional immune cells participate in the pathogenesis of a variety of autoimmune diseases, although the specific mechanisms remain elusive and effective clinical interventions are lacking. Recent research on immune checkpoint molecules has revealed significant expression of T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) on the surfaces of various immune cells. These include different subsets of T cells, macrophages, dendritic cells, natural killer cells, and mast cells. Further investigation into its protein structure, ligands, and intracellular signaling pathway activation mechanisms has found that TIM-3, by binding with different ligands, is involved in the regulation of crucial biological processes such as proliferation, apoptosis, phenotypic transformation, effector protein synthesis, and cellular interactions of various immune cells. The TIM-3-ligand axis plays a pivotal role in the pathogenesis of numerous conditions, including autoimmune diseases, infections, cancers, transplant rejection, and chronic inflammation. This article primarily focuses on the research findings of TIM-3 in the field of autoimmune diseases, with a special emphasis on the structure and signaling pathways of TIM-3, its types of ligands, and the potential mechanisms implicated in systemic lupus erythematosus, multiple sclerosis, rheumatoid arthritis, as well as other autoimmune diseases and chronic inflammation. The latest research results in the field of immunology suggest that TIM-3 dysfunction affects various immune cells and participates in the pathogenesis of diseases. Monitoring the activity of its receptor-ligand axis can serve as a novel biological marker for disease clinical diagnosis and prognosis evaluation. More importantly, the TIM-3-ligand axis and the downstream signaling pathway molecules may become key targets for targeted intervention treatment of autoimmune-related diseases.

TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy

TL1A Modulates the Severity of Colitis by Promoting Th9 Differentiation and IL-9 Secretion.

TM9SF4 Is a Crucial Regulator of Inflammation and ER Stress in Inflammatory Bowel Disease

Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3.

Toll-like Receptor 9 is Correlated to Disease Activity in Chinese Systemic Lupus Erythematosus Population.

TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology

Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1

Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials

Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice.

TMX1, a disulfide oxidoreductase, is necessary for T cell function through regulation of CD3ζ

TMX1, a disulfide oxidoreductase, is necessary for T cell function through regulation of CD3zeta

Toll‐like Receptor 9 Signaling is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor Β–dependent Fibroblast Activation

Aire and Fezf2, two regulators in medullary thymic epithelial cells, control autoimmune diseases by regulating TSAs: Partner or complementer?

TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse Model

TM9SF1 Promotes Bladder Cancer Cell Growth and Infiltration

T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases

ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1

Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review

Targeting T-helper 9 Cells and Interleukin-9 in Autoimmune Diseases.

CCR9 Expressing T Helper and T Follicular Helper Cells Exhibit Site-Specific Identities During Inflammatory Disease

Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development